documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
77 rows where docket_id = "FDA-2000-N-0044" and posted_year = 2006 sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: subtype, posted_date, posted_month, last_modified, posted_date (date), comment_start_date (date), last_modified (date)
document_type 3
- Supporting & Related Material 46
- Other 27
- Notice 4
posted_year 1
- 2006 · 77 ✖
agency_id 1
- FDA 77
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2000-N-0044-0083 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | FDA/OES to National Medical Association - Answer | Other | ANS-Answer | 2006-06-14T04:00:00Z | 2006 | 6 | 2013-08-11T02:35:36Z | 0 | 0 | 09000064804af130 | |||
| FDA-2000-N-0044-0084 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | OMB Review Published 1/24/2006 | Supporting & Related Material | REF-Reference (internal unless indicated) | 2006-04-26T04:00:00Z | 2006 | 4 | 2008-07-30T00:03:19Z | 0 | 0 | 09000064804af132 | |||
| FDA-2000-N-0044-0086 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | OMB Review Published 1/24/2006 | Supporting & Related Material | REF-Reference (internal unless indicated) | 2006-04-26T04:00:00Z | 2006 | 4 | 2008-07-30T00:11:09Z | 0 | 0 | 09000064804af134 | |||
| FDA-2000-N-0044-0085 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | OMB Review Published 1/24/2006 | Supporting & Related Material | REF-Reference (internal unless indicated) | 2006-04-26T04:00:00Z | 2006 | 4 | 2008-07-30T00:06:38Z | 0 | 0 | 09000064804af133 | |||
| FDA-2000-N-0044-0077 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | FDA/HF-40 to California Orthopaedic Association | Other | LET-Letter | 2006-03-14T05:00:00Z | 2006 | 3 | 2013-07-27T20:59:25Z | 0 | 0 | 09000064804af11d | |||
| FDA-2000-N-0044-0082 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | HF-40 Michigan State Medical Society (MSMS) | Other | LET-Letter | 2006-03-14T05:00:00Z | 2006 | 3 | 2008-04-25T01:01:09Z | 0 | 0 | 09000064804af127 | |||
| FDA-2000-N-0044-0079 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | FDA/HF-40 to Wyoming Epilepsy Association | Other | LET-Letter | 2006-03-14T05:00:00Z | 2006 | 3 | 2013-07-27T20:59:25Z | 0 | 0 | 09000064804af123 | |||
| FDA-2000-N-0044-0080 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | Wyoming Epilepsy Association - Attachment | Other | EXB-Exhibit | 2006-03-14T05:00:00Z | 2006 | 3 | 2013-07-27T20:59:25Z | 0 | 0 | 09000064804af124 | |||
| FDA-2000-N-0044-0078 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | FDA/HF-40 to Asthma & Allergy Foundation of America (AAFA) | Other | LET-Letter | 2006-03-14T05:00:00Z | 2006 | 3 | 2008-07-29T20:27:11Z | 0 | 0 | 09000064804af120 | |||
| FDA-2000-N-0044-0081 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | Wyoming Epilepsy Association - Attachment | Other | EXB-Exhibit | 2006-03-14T05:00:00Z | 2006 | 3 | 2008-07-29T21:26:59Z | 0 | 0 | 09000064804af125 | |||
| FDA-2000-N-0044-0076 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | FDA/HF-40 to Bennett's Creek Pharmacy | Other | LET-Letter | 2006-03-08T05:00:00Z | 2006 | 3 | 2013-07-27T20:59:25Z | 0 | 0 | 09000064804af115 | |||
| FDA-2000-N-0044-0075 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | HF-40 to Commonwealth of Virginia | Other | LET-Letter | 2006-03-08T05:00:00Z | 2006 | 3 | 2013-07-27T20:59:24Z | 0 | 0 | 09000064804af113 | |||
| FDA-2000-N-0044-0072 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | Food and Drug Administration | Other | M-Memorandum | 2006-03-01T05:00:00Z | 2006 | 3 | 2013-07-27T20:59:24Z | 0 | 0 | 09000064804af110 | |||
| FDA-2000-N-0044-0073 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | Food and Drug Administration | Other | M-Memorandum | 2006-03-01T05:00:00Z | 2006 | 3 | 2008-07-29T16:53:54Z | 0 | 0 | 09000064804af111 | |||
| FDA-2000-N-0044-0063 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | FDA/HF-40 to Commonwealth of Virginia House of Delegates | Other | LET-Letter | 2006-02-24T05:00:00Z | 2006 | 2 | 2008-07-29T16:09:54Z | 0 | 0 | 09000064804af105 | |||
| FDA-2000-N-0044-0069 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | HF-40 to Commonwealth of Virginia | Other | LET-Letter | 2006-02-24T05:00:00Z | 2006 | 2 | 2013-07-28T01:36:03Z | 0 | 0 | 09000064804af10d | |||
| FDA-2000-N-0044-0067 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | FDA/HF-40 to Florida Academy of Family Physicians | Other | LET-Letter | 2006-02-24T05:00:00Z | 2006 | 2 | 2008-07-29T16:35:06Z | 0 | 0 | 09000064804af10b | |||
| FDA-2000-N-0044-0065 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | FDA/HF-40 to Senate of Virginia | Other | LET-Letter | 2006-02-24T05:00:00Z | 2006 | 2 | 2013-07-27T20:59:24Z | 0 | 0 | 09000064804af107 | |||
| FDA-2000-N-0044-0061 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | FDA/HF-40 to Oklahoma Osteopathic Association | Other | LET-Letter | 2006-02-24T05:00:00Z | 2006 | 2 | 2008-07-29T15:14:50Z | 0 | 0 | 09000064804af103 | |||
| FDA-2000-N-0044-0066 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | FDA/HF-40 to Alliance for Health, Education and Development (AHEAD) | Other | LET-Letter | 2006-02-24T05:00:00Z | 2006 | 2 | 2013-07-27T20:59:24Z | 0 | 0 | 09000064804af109 | |||
| FDA-2000-N-0044-0071 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | HF-40 to State of Louisiana | Other | LET-Letter | 2006-02-24T05:00:00Z | 2006 | 2 | 2013-08-11T04:09:08Z | 0 | 0 | 09000064804af10f | |||
| FDA-2000-N-0044-0057 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | FDA/HF-40 to Epilepsy Foundation | Other | LET-Letter | 2006-02-23T05:00:00Z | 2006 | 2 | 2013-07-27T20:59:24Z | 0 | 0 | 09000064804af0fa | |||
| FDA-2000-N-0044-0053 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | HF-40 to California Academy of Physician Assistants (CAPA) | Other | LET-Letter | 2006-02-23T05:00:00Z | 2006 | 2 | 2008-07-28T21:33:31Z | 0 | 0 | 09000064804af0f0 | |||
| FDA-2000-N-0044-0060 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | FDA/HF-40 to Osteopathic Physicians & Surgeons of California (OPSC) | Other | LET-Letter | 2006-02-23T05:00:00Z | 2006 | 2 | 2013-07-27T20:59:24Z | 0 | 0 | 09000064804af100 | |||
| FDA-2000-N-0044-0055 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | FDA to Colorado Council of Black Nurses, Inc. | Other | LET-Letter | 2006-02-23T05:00:00Z | 2006 | 2 | 2013-07-27T20:59:24Z | 0 | 0 | 09000064804af0f6 | |||
| FDA-2000-N-0044-0059 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | FDA/HF-40 to Epilepsy Foundation Middle and West Tennessee | Other | LET-Letter | 2006-02-23T05:00:00Z | 2006 | 2 | 2013-07-27T20:59:24Z | 0 | 0 | 09000064804af0fe | |||
| FDA-2000-N-0044-0058 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | FDA/HF-40 to Civil Justice Association of California | Other | LET-Letter | 2006-02-23T05:00:00Z | 2006 | 2 | 2013-07-27T20:59:24Z | 0 | 0 | 09000064804af0fc | |||
| FDA-2000-N-0044-0052 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | FDA to Health Care Advocacy Alliance (HCAA) | Other | LET-Letter | 2006-02-23T05:00:00Z | 2006 | 2 | 2008-07-29T21:33:28Z | 0 | 0 | 09000064804af0ec | |||
| FDA-2000-N-0044-0054 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | FDA to National Association of Hispanic Nurses (NAHN) | Other | LET-Letter | 2006-02-23T05:00:00Z | 2006 | 2 | 2008-07-28T21:52:31Z | 0 | 0 | 09000064804af0f3 | |||
| FDA-2000-N-0044-0056 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | FDA/HF-40 to The Literacy Council | Other | LET-Letter | 2006-02-23T05:00:00Z | 2006 | 2 | 2013-08-11T04:09:08Z | 0 | 0 | 09000064804af0f8 | |||
| FDA-2000-N-0044-0049 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | Supporting Statement | Supporting & Related Material | SS-Supporting Statement | 2006-02-06T05:00:00Z | 2006 | 2 | 2008-07-28T18:13:12Z | 0 | 0 | 09000064804af0e5 | |||
| FDA-2000-N-0044-0051 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | Requirements on Content and Format of Labeling for Human Prescription Drugs and Biologics; Requirements for Prescription Drug Porduct Lables; Agency Information Collection Activities; Announcement of Office of Management and Budget Approval - Notice | Notice | NAL-Notice of Approval | 2006-02-06T05:00:00Z | 2006 | 2 | 2006-02-03T05:00:00Z | 2008-08-05T16:22:32Z | 0 | 0 | 09000064804af0e7 | ||
| FDA-2000-N-0044-0050 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | Supporting Statement | Supporting & Related Material | SS-Supporting Statement | 2006-02-06T05:00:00Z | 2006 | 2 | 2008-04-25T01:01:11Z | 0 | 0 | 09000064804af0e6 | |||
| FDA-2000-N-0044-0027 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | Background Material | Supporting & Related Material | BKG-Background Material | 2006-01-30T05:00:00Z | 2006 | 1 | 2008-04-25T01:01:11Z | 0 | 0 | 09000064804af0ce | |||
| FDA-2000-N-0044-0045 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | Background Material | Supporting & Related Material | BKG-Background Material | 2006-01-30T05:00:00Z | 2006 | 1 | 2008-04-25T01:01:12Z | 0 | 0 | 09000064804af0e0 | |||
| FDA-2000-N-0044-0038 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | Background Material | Supporting & Related Material | BKG-Background Material | 2006-01-30T05:00:00Z | 2006 | 1 | 2008-04-25T01:01:14Z | 0 | 0 | 09000064804af0d9 | |||
| FDA-2000-N-0044-0026 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | Background Material | Supporting & Related Material | BKG-Background Material | 2006-01-30T05:00:00Z | 2006 | 1 | 2008-04-25T01:01:13Z | 0 | 0 | 09000064804af0cd | |||
| FDA-2000-N-0044-0034 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | Background Material | Supporting & Related Material | BKG-Background Material | 2006-01-30T05:00:00Z | 2006 | 1 | 2008-04-25T01:01:11Z | 0 | 0 | 09000064804af0d5 | |||
| FDA-2000-N-0044-0044 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | Background Material | Supporting & Related Material | BKG-Background Material | 2006-01-30T05:00:00Z | 2006 | 1 | 2008-04-25T01:01:11Z | 0 | 0 | 09000064804af0df | |||
| FDA-2000-N-0044-0041 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | Background Material | Supporting & Related Material | BKG-Background Material | 2006-01-30T05:00:00Z | 2006 | 1 | 2008-04-25T01:01:11Z | 0 | 0 | 09000064804af0dc | |||
| FDA-2000-N-0044-0039 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | Background Material | Supporting & Related Material | BKG-Background Material | 2006-01-30T05:00:00Z | 2006 | 1 | 2008-04-25T01:01:14Z | 0 | 0 | 09000064804af0da | |||
| FDA-2000-N-0044-0009 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | Background Material | Supporting & Related Material | BKG-Background Material | 2006-01-30T05:00:00Z | 2006 | 1 | 2008-04-25T01:01:13Z | 0 | 0 | 09000064804af0ba | |||
| FDA-2000-N-0044-0017 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | Background Material | Supporting & Related Material | BKG-Background Material | 2006-01-30T05:00:00Z | 2006 | 1 | 2008-04-25T01:01:11Z | 0 | 0 | 09000064804af0c3 | |||
| FDA-2000-N-0044-0031 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | Background Material | Supporting & Related Material | BKG-Background Material | 2006-01-30T05:00:00Z | 2006 | 1 | 2008-04-25T01:01:09Z | 0 | 0 | 09000064804af0d2 | |||
| FDA-2000-N-0044-0043 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | Background Material | Supporting & Related Material | BKG-Background Material | 2006-01-30T05:00:00Z | 2006 | 1 | 2008-04-25T01:01:14Z | 0 | 0 | 09000064804af0de | |||
| FDA-2000-N-0044-0010 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | Background Material | Supporting & Related Material | BKG-Background Material | 2006-01-30T05:00:00Z | 2006 | 1 | 2008-04-25T01:01:13Z | 0 | 0 | 09000064804af0bb | |||
| FDA-2000-N-0044-0035 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | Background Material | Supporting & Related Material | BKG-Background Material | 2006-01-30T05:00:00Z | 2006 | 1 | 2008-04-25T01:01:11Z | 0 | 0 | 09000064804af0d6 | |||
| FDA-2000-N-0044-0033 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | Background Material | Supporting & Related Material | BKG-Background Material | 2006-01-30T05:00:00Z | 2006 | 1 | 2008-04-25T01:01:10Z | 0 | 0 | 09000064804af0d4 | |||
| FDA-2000-N-0044-0020 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | Background Material | Supporting & Related Material | BKG-Background Material | 2006-01-30T05:00:00Z | 2006 | 1 | 2008-04-25T01:01:13Z | 0 | 0 | 09000064804af0c7 | |||
| FDA-2000-N-0044-0016 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | Background Material | Supporting & Related Material | BKG-Background Material | 2006-01-30T05:00:00Z | 2006 | 1 | 2008-04-25T01:01:14Z | 0 | 0 | 09000064804af0c2 | |||
| FDA-2000-N-0044-0014 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | Background Material | Supporting & Related Material | BKG-Background Material | 2006-01-30T05:00:00Z | 2006 | 1 | 2008-04-25T01:01:13Z | 0 | 0 | 09000064804af0bf | |||
| FDA-2000-N-0044-0018 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | Background Material | Supporting & Related Material | BKG-Background Material | 2006-01-30T05:00:00Z | 2006 | 1 | 2008-04-25T01:01:13Z | 0 | 0 | 09000064804af0c4 | |||
| FDA-2000-N-0044-0024 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | Background Material | Supporting & Related Material | BKG-Background Material | 2006-01-30T05:00:00Z | 2006 | 1 | 2008-04-25T01:01:09Z | 0 | 0 | 09000064804af0cb | |||
| FDA-2000-N-0044-0021 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | Background Material | Supporting & Related Material | BKG-Background Material | 2006-01-30T05:00:00Z | 2006 | 1 | 2008-04-25T01:01:11Z | 0 | 0 | 09000064804af0c8 | |||
| FDA-2000-N-0044-0046 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | Background Material | Supporting & Related Material | BKG-Background Material | 2006-01-30T05:00:00Z | 2006 | 1 | 2008-04-25T01:01:09Z | 0 | 0 | 09000064804af0e1 | |||
| FDA-2000-N-0044-0030 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | Background Material | Supporting & Related Material | BKG-Background Material | 2006-01-30T05:00:00Z | 2006 | 1 | 2008-04-25T01:01:09Z | 0 | 0 | 09000064804af0d1 | |||
| FDA-2000-N-0044-0037 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | Background Material | Supporting & Related Material | BKG-Background Material | 2006-01-30T05:00:00Z | 2006 | 1 | 2008-04-25T01:01:12Z | 0 | 0 | 09000064804af0d8 | |||
| FDA-2000-N-0044-0028 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | Background Material | Supporting & Related Material | BKG-Background Material | 2006-01-30T05:00:00Z | 2006 | 1 | 2008-04-25T01:01:13Z | 0 | 0 | 09000064804af0cf | |||
| FDA-2000-N-0044-0029 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | Background Material | Supporting & Related Material | BKG-Background Material | 2006-01-30T05:00:00Z | 2006 | 1 | 2008-04-25T01:01:10Z | 0 | 0 | 09000064804af0d0 | |||
| FDA-2000-N-0044-0012 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | Background Material | Supporting & Related Material | BKG-Background Material | 2006-01-30T05:00:00Z | 2006 | 1 | 2008-04-25T01:01:10Z | 0 | 0 | 09000064804af0bd | |||
| FDA-2000-N-0044-0011 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | Background Material | Supporting & Related Material | BKG-Background Material | 2006-01-30T05:00:00Z | 2006 | 1 | 2008-04-25T01:01:14Z | 0 | 0 | 09000064804af0bc | |||
| FDA-2000-N-0044-0022 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | Background Material | Supporting & Related Material | BKG-Background Material | 2006-01-30T05:00:00Z | 2006 | 1 | 2008-04-25T01:01:09Z | 0 | 0 | 09000064804af0c9 | |||
| FDA-2000-N-0044-0019 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | Background Material | Supporting & Related Material | BKG-Background Material | 2006-01-30T05:00:00Z | 2006 | 1 | 2008-04-25T01:01:09Z | 0 | 0 | 09000064804af0c5 | |||
| FDA-2000-N-0044-0015 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | Background Material | Supporting & Related Material | BKG-Background Material | 2006-01-30T05:00:00Z | 2006 | 1 | 2008-04-25T01:01:12Z | 0 | 0 | 09000064804af0c1 | |||
| FDA-2000-N-0044-0008 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | Background Material | Supporting & Related Material | BKG-Background Material | 2006-01-30T05:00:00Z | 2006 | 1 | 2008-04-25T01:01:10Z | 0 | 0 | 09000064804af0b9 | |||
| FDA-2000-N-0044-0013 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | Background Material | Supporting & Related Material | BKG-Background Material | 2006-01-30T05:00:00Z | 2006 | 1 | 2008-04-25T01:01:10Z | 0 | 0 | 09000064804af0be | |||
| FDA-2000-N-0044-0047 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | Background Material | Supporting & Related Material | BKG-Background Material | 2006-01-30T05:00:00Z | 2006 | 1 | 2008-04-25T01:01:09Z | 0 | 0 | 09000064804af0e3 | |||
| FDA-2000-N-0044-0032 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | Background Material | Supporting & Related Material | BKG-Background Material | 2006-01-30T05:00:00Z | 2006 | 1 | 2008-04-25T01:01:09Z | 0 | 0 | 09000064804af0d3 | |||
| FDA-2000-N-0044-0025 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | Background Material | Supporting & Related Material | BKG-Background Material | 2006-01-30T05:00:00Z | 2006 | 1 | 2008-04-25T01:01:13Z | 0 | 0 | 09000064804af0cc | |||
| FDA-2000-N-0044-0023 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | Background Material | Supporting & Related Material | BKG-Background Material | 2006-01-30T05:00:00Z | 2006 | 1 | 2008-04-25T01:01:11Z | 0 | 0 | 09000064804af0ca | |||
| FDA-2000-N-0044-0036 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | Background Material | Supporting & Related Material | BKG-Background Material | 2006-01-30T05:00:00Z | 2006 | 1 | 2008-04-25T01:01:09Z | 0 | 0 | 09000064804af0d7 | |||
| FDA-2000-N-0044-0042 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | Background Material | Supporting & Related Material | BKG-Background Material | 2006-01-30T05:00:00Z | 2006 | 1 | 2008-04-25T01:01:10Z | 0 | 0 | 09000064804af0dd | |||
| FDA-2000-N-0044-0040 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | Background Material | Supporting & Related Material | BKG-Background Material | 2006-01-30T05:00:00Z | 2006 | 1 | 2008-04-25T01:01:12Z | 0 | 0 | 09000064804af0db | |||
| FDA-2000-N-0044-0048 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | Background Material | Supporting & Related Material | BKG-Background Material | 2006-01-30T05:00:00Z | 2006 | 1 | 2008-04-25T01:01:09Z | 0 | 0 | 09000064804af0e4 | |||
| FDA-2000-N-0044-0006 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | Requirements on Content and Format of Labeling for Human Prescription Drugs and Biological Products - Notice of Final Rule (part 3 of 3) | Notice | NFR-Notice of Final Rule | 2006-01-24T05:00:00Z | 2006 | 1 | 2011-06-11T16:25:49Z | 0 | 0 | 09000064804af0b5 | |||
| FDA-2000-N-0044-0005 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | Requirements on Content and Format of Labeling for Human Prescription Drugs and Biological Products - Notice of Final Rule (part 1 of 3) | Notice | NFR-Notice of Final Rule | 2006-01-24T05:00:00Z | 2006 | 1 | 2011-06-11T16:25:50Z | 71FR3922 | 0 | 0 | 09000064804af0b4 | ||
| FDA-2000-N-0044-0007 | FDA | Labeling for Human Prescription Drug/Biologic Products-CLOSED FDA-2000-N-0044 | Requirements on Content and Format of Labeling for Human Prescription Drugs and Biological Products - Notice of Final Rule (part 2 of 3) | Notice | NFR-Notice of Final Rule | 2006-01-24T05:00:00Z | 2006 | 1 | 2011-06-11T16:25:49Z | 0 | 0 | 09000064804af0b6 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);